Assessing the value of mepolizumab for severe eosinophilic...

Annals of Allergy, Asthma & Immunology 2017 / 02 Vol. 118; Iss. 2

Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis

Whittington, Melanie D., McQueen, R. Brett, Ollendorf, Daniel A., Tice, Jeffrey A., Chapman, Richard H., Pearson, Steven D., Campbell, Jonathan D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
118
Language:
english
Journal:
Annals of Allergy, Asthma & Immunology
DOI:
10.1016/j.anai.2016.10.028
Date:
February, 2017
File:
PDF, 542 KB
english, 2017
Conversion to is in progress
Conversion to is failed